Market Tracker

09/23 5:16pm ET

Becton Dickinson and Co (NYSE:BDX)

179.50
Delayed Data
As of Sep 23
 -2.05 / -1.13%
Today’s Change
128.87
Today|||52-Week Range
181.76
+16.49%
Year-to-Date
Becton (BDX) to Expand Syringe Capacity at Holdrege Facility
Sep 23 / Zacks.com - Paid Partner Content
Avery Dennison (AVY) & BD Launch New Vascular Dressings
Sep 19 / Zacks.com - Paid Partner Content
Becton, Dickinson (BDX) Launch Wireless Diagnostic Device
Sep 22 / Zacks.com - Paid Partner Content
Becton, Dickinson (BDX) Gets USFDA Clearance for BD MAX
Sep 15 / Zacks.com - Paid Partner Content
Becton, Dickinson (BDX) Introduces New Vascular Dressing
Sep 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close181.55
Today’s open179.20
Day’s range177.48 - 180.40
Volume1,175,868
Average volume (3 months)835,096
Market cap$38.2B
Dividend yield1.47%
Data as of 4:00pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-44.07%
Earnings growth (this year)+19.78%
Earnings growth (next 5 years)+11.20%
Revenue growth (last year)+21.94%
P/E ratio34.3
Price/Sales2.68
Price/Book5.28

Competitors

 Today’s
change
Today’s
% change
BSXBoston Scientific Co...-0.02-0.08%
ZBHZimmer Biomet Holdin...-0.54-0.42%
BCRC R Bard Inc-1.44-0.62%
DXCMDexCom Inc-0.11-0.12%
Data as of 4:02pm ET, 09/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$2.10
Annual revenue (last year)$10.3B
Annual profit (last year)$695.0M
Net profit margin6.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Vincent A. Forlenza
EVP, Chief Financial &
Administrative Officer
Christopher R. Reidy
Corporate headquarters
Franklin Lakes, New Jersey

Forecasts